首页 > 抗体蛋白 > 抗体
Anti-TYRP1 (MEL-5) Antibody (Previously Covance ca
产品名称:
Anti-TYRP1 (MEL-5) Antibody (Previously Covance ca
产品类别:
抗体
产品编号:
917801
产品应用:
917801
[价格]
规格 价格 库存
1mL ¥ 5488 1

产品详情

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Ta99 was developed using a SK-MEL-23 Melanoma cell line.
Formulation
Phosphate-buffered solution with BSA + 0.1% NaN3.
Preparation
The antibody was purified by affinity chromatography.
Storage & Handling
Store between 2°C and 8°C.
Application

IHC-F - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunohistochemical staining.

The optimal working dilution should be determined for each specific assay condition.
? IHC: ≥1:20 (concentrated format) with Biotin based detection systems such as USA Ultra Streptavidin Detection (Cat. No. 929501).

Tissue Sections: The preferred specimens for this antibody are frozen tissue sections and/or cytocentrifuge preparations fixed 10 minutes in 4°C acetone.
Pretreatment: Not required.
Incubation: 60 minutes at room temperature

Application Notes

This antibody is effective in immunohistochemistry (IHC).

Positive tissue (human): Melanoma, normal skin

The BioLegend Mel 5 (Ta99) monoclonal antibody recognizes gp75, an abundant intracellular glycoprotein that is expressed in the melanosomes of human melanocytes and melanomas.

Application References

(PubMed link indicates BioLegend citation)
  1. Gross EA, et al. 1999. Archives Dermatol. 135:15.
  2. Bhawan, J, Cao SL. 1999. Am. J. Dermatopathol. 21:225.
  3. Kemp EH, et al. 1998. Br J Dermatol. 139:798.
  4. Burkhalter A, White WL. 1997. Am J Dermapathol. 19:303.
  5. Andersen WK, et al. 1997. J Am Acad Dermatol. 36:444.
  6. Bhawan J. 1997. Melanoma Res. 7:43.
  7. Zhao H, et al. 1996. J Invest Dermatol. 106:744.
  8. Cui J, et al. 1995. Pigment Cell Res. 8:53.
  9. Vijayasaradhi S, Houghton AN. 1991. Int J Cancer. 47:298.
  10. Thomson TM, et al. 1988. J Invest Dermatol. 90:459.
Product Citations
  1. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  2. Zurina IM, et al. 2020. Front Bioeng Biotechnol. 0.708333333. PubMed
  3. Jackson E, et al. 2019. Int J Mol Sci. 5.099305556. PubMed
RRID
AB_2565201 (BioLegend Cat. No. 917801)

联系我们

TEL:021-34661275  点击拨打热线